- Open Access
Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer
BMC Cancer volume 16, Article number: 939 (2016)
- The original article was published in BMC Cancer 2016 16:822
After the publication of the article , the authors realised it contained an error with the Methods section. The following paragraph should be deleted from the original article:
Cell proliferation assay
Proliferation was measured using Delfia cell proliferation kit (Perkin-Elmer, Waltham, MA, USA) according to manufacturer protocol. BrdU incorporation was measured by time–resolved fluorescence 48 h after transfection using VictorX4 multimode plate reader (Perkin-Elmer, Waltham, MA, USA). All experiments were performed in triplicates and repeated tree times.
Please note that the original article was corrected.
Torres A, et al. In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer. BMC Cancer. 2016;16:822. doi:10.1186/s12885-016-2867-z.
The online version of the original article can be found under doi:10.1186/s12885-016-2867-z.
About this article
Cite this article
Torres, A., Kozak, J., Korolczuk, A. et al. Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer. BMC Cancer 16, 939 (2016). https://doi.org/10.1186/s12885-016-2971-0